• About us
  • Contact us
  • Our team
  • Terms of Service
Saturday, November 14, 2026
Kashmir Images - Latest News Update
Epaper
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER
No Result
View All Result
Kashmir Images - Latest News Update
No Result
View All Result
Home NATION

Parliamentary panel calls for framing price control regime for COVID medicines, medical devices

Press Trust of india by Press Trust of india
March 21, 2022
in NATION
A A
0
Parliament approves repeal of farm laws; Opposition protests demanding debate
FacebookTwitterWhatsapp

New Delhi: A Parliamentary panel has recommended framing a new price control regime specific for medicines and medical devices for COVID-19 management and put them under price control with no annual increase in prices allowed till the pandemic is entirely over in the country.

The Parliamentary Standing Committee on Chemicals and Fertilisers, in its report on availability of medicines and medical devices for COVID-19 management tabled in the Lok Sabha on Monday also recommended covering medical devices for COVID-19 treatment under National List of Essential Medicines for effective price control, while also suggesting exemption of basic customs duty and GST on medicines and medical devices for fighting the pandemic.

More News

Young, Henry wreck India to power NZ to 244-run win in 4th ODI

Centre extends ban on Zakir Naik’s IRF for 5 years; Amit Shah says his group promotes ‘venomous ideology’

Proof of allegations against Modi on my phone, which PM taps: Rahul

Load More

Citing the example of non-scheduled drug Remdesivir the price for which varied up to Rs 5,400 per vial but reduced to less than Rs 3,500 per vial voluntarily by major manufacturers and marketers after “proactive” government intervention, the panel suggested effective price control of non-scheduled COVID-19 related medicines and medical devices.

It recommended the DoP and NPPA to “frame a new price control regime specific for medicines and medical devices for COVID-19 management where the distinction between the scheduled and non-scheduled drugs may be done away with and all such medicines and medical devices are put under price control with no annual increase in prices allowed till the pandemic is entirely over in the country”.

The committee said it was informed that at the beginning of the COVID-19 pandemic in February 2020, India was dependent on high-end imported ventilators and to meet the need of states and hospitals for ventilators, domestic production of ICU ventilators was encouraged. Orders for around 60,000 ventilators were placed for supply to states and Union Territories (UTs).

Ventilators have been notified by the Ministry of Health and Family Welfare (MoHFW) as drugs under Drugs & Cosmetic Act, 1940 from April 1, 2020 and it is presently under voluntarily licensing regime of CDSCO (Central Drugs Standard Control Organisation) for 42 months till September 2023, it added.

Stating that ventilator is a non-scheduled medical device, the panel said a manufacturer or importer is at liberty to fix the maximum retail price launched by it, but cannot increase it by more than 10 per cent during preceding 12 months.

Since the ventilators are also covered under voluntary licensing regime, the committee said it felt that all medical devices like ventilators, oxygen concentrators should be kept under scheduled drugs category by the Department of Pharmaceuticals (DoP) and NPPA (National Pharmaceuticals Pricing Authority) so that these medical devices can be made available to the people and hospitals at affordable prices till the pandemic is completely over.

“The Committee, therefore, recommend that all medical devices critical to COVID-19 treatment like ventilators, oxygen concentrators etc. should be covered under the National List of Essential Medicines for effective price control,” the report said.

DoP can also consider manufacturing of ventilators by pharma PSUs under it to make available quality ventilators at competitive prices to the hospitals, it added.

The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19.

“Since the pandemic is creating wave after wave and the people of the country are under constant threat, the committee feel that though the GST council has reduced the GST on COVID related medicines and medical devices, the need of the hour is to make these products more affordable to the people,” it said.

It suggested that DoP in coordination with MoHFW should “submit a proposal to GST Council to explore the possibility of exempting all the essential medicines and medical devices including, liquid medical oxygen, oxygen concentrators, ventilators, pulse oximeters, hand sanitizers, temperature check equipment, etc used for the treatment of COVID 19 from the purview of GST”.

Further, it said basic customs duty exemptions on various medicines and medical devices related to COVID 19 may also be continued till the pandemic is over.

Arguing that the price range of the oxygen concentrators is still on the higher side even after trade margin rationalisation (TMR), the panel recommended that the DoP and the NPPA should consider capping of the prices of various types of oxygen concentrators so as to make them affordable to common man.

Previous Post

‘The Kashmir Files’ creating situation that may harm country: CPI(M) leader Yechury

Next Post

Employers having 10 or more employees must have committee to probe sexual harassment complaints

Press Trust of india

Press Trust of india

Related Posts

Young, Henry wreck India to power NZ to 244-run win in 4th ODI

November 13, 2026

Mount Maunganui: Familiar foe Matt Henry cut open old wounds as India's much-vaunted batting line-up fell apart in the team's...

Read moreDetails

Centre extends ban on Zakir Naik’s IRF for 5 years; Amit Shah says his group promotes ‘venomous ideology’

HC refuses to grant relief to Zakir Naik
November 13, 2026

  New Delhi, Nov 13 (PTI) The Centre on Friday extended the ban on fugitive preacher Zakir Naik's Islamic Research...

Read moreDetails

Proof of allegations against Modi on my phone, which PM taps: Rahul

NDA govt at Centre ‘crippled’; opposition dealt fatal blow to BJP: Rahul Gandhi
November 13, 2026

New Delhi: Upping the ante over his debate dare to Prime Minister Narendra Modi, Congress leader Rahul Gandhi on Friday...

Read moreDetails

Rahul Gandhi ‘habitual liar’: BJP on Congress leader’s phone tapping allegation

Rahul Gandhi ‘habitual liar’: BJP on Congress leader’s phone tapping allegation
November 13, 2026

New Delhi:  The BJP on Friday hit out at Lok Sabha Leader of Opposition Rahul Gandhi over his allegation of...

Read moreDetails

Phone tapping is a reality in India: Prashant Kishor on Rahul’s claims

November 13, 2026

Patna:  Jan Suraaj Party founder Prashant Kishor on Friday claimed that tapping of phones was a "reality" in the country,...

Read moreDetails

India seeks ‘positive’ and ‘forward-looking’ relationship with Bangladesh: MEA

November 13, 2026

New Delhi:  India on Friday said it desires a "positive, constructive and forward-looking" relationship with Bangladesh, remarks that came amid...

Read moreDetails
Next Post
Employers having 10 or more employees must have committee to probe sexual harassment complaints

Employers having 10 or more employees must have committee to probe sexual harassment complaints

  • About us
  • Contact us
  • Our team
  • Terms of Service
E-Mailus: kashmirimages123@gmail.com

© 2025 Kashmir Images - Designed by GITS.

No Result
View All Result
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER

© 2025 Kashmir Images - Designed by GITS.